Cephalgia Alopecia

被引:4
作者
Bedrin, Kate O. [1 ]
Dougherty, Carrie [1 ]
机构
[1] MedStar Georgetown Univ Hosp, Dept Neurol, 3800 Reservoir Rd NW,7 PHC, Washington, DC 20007 USA
关键词
Cephalgia alopecia; Headache; Nummular headache; Alopecia areata; NUMMULAR HEADACHE; SUBSTANCE-P; AREATA;
D O I
10.1007/s11916-020-00880-w
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose of ReviewIn this review, we examine reported cases of cephalgia alopecia including the initial case report from 2006. The goal is to review the clinical description, pathophysiology, diagnosis, and treatment of cephalgia alopecia.Recent FindingsThe pathophysiology of the headache and hair loss in cephalgia alopecia is believed to be related to neuroregulation of skin and nerve. It is hypothesized that the headache causes recurrent activation of trigeminal and upper cervical branches that innervate the hair cells. The repetitive activation of C fibers results in depletion of substance P and calcitonin gene-related peptide (CGRP), which leads to loss of hair growth promotion and disruption of immune system regulation. A case report suggests that cephalgia alopecia and nummular headache with trophic changes may represent a spectrum of disease involving head pain and cutaneous changes.SummaryCephalgia alopecia is a rare headache disorder described as recurrent burning, stabbing head, and neck pain that is followed by hair loss in the corresponding region of the scalp. The mainstay treatment for both pain and hair loss is OnabotulinumtoxinA (onabotA). A patient's clinical history and response to onabotA treatment is used to make the diagnosis. Future research is needed to examine the hypothesized disease continuum of head pain and cutaneous changes. It will also be beneficial to assess if the grid-like onabotA technique used in nummular headache is effective in cephalgia alopecia. In addition, further studies are needed to assess the proposed pathophysiology.
引用
收藏
页数:4
相关论文
共 10 条
  • [1] Botulinum toxin treatment of cephalalgia alopecia increases substance P and calcitonin gene-related peptide-containing cutaneous nerves in scalp
    Cutrer, F. M.
    Sandroni, P.
    Wendelschafer-Crabb, G.
    [J]. CEPHALALGIA, 2010, 30 (08) : 1000 - 1006
  • [2] Cephalalgic alopecia areata: a syndrome of neuralgiform head pain and hair loss responsive to botulinum A toxin injection
    Cutrer, FM
    Pittelkow, MR
    [J]. CEPHALALGIA, 2006, 26 (06) : 747 - 751
  • [3] Monotherapy for Alopecia Areata: A Systematic Review and Network Meta-Analysis
    Gupta, Aditya K.
    Carviel, Jessie L.
    Foley, Kelly A.
    Shear, Neil H.
    Piraccini, Bianca Maria
    Piguet, Vincent
    Tosti, Antonella
    [J]. SKIN APPENDAGE DISORDERS, 2019, 5 (06): : 331 - 337
  • [4] Cephalalgia Alopecia or Nummular Headache With Trophic Changes? A New Case With Prolonged Follow-Up
    Irimia, Pablo
    Palma, Jose-Alberto
    Angel Idoate, Miguel
    Espana, Agustin
    Riverol, Mario
    Martinez-Vila, Eduardo
    [J]. HEADACHE, 2013, 53 (06): : 994 - 997
  • [5] Trichoscopy features of trichotillomania
    Martin, Jose M.
    Montesinos, Encarnacion
    Cordero, Pilar
    Gonzalez, Victor
    Ramon, Dolores
    [J]. PEDIATRIC DERMATOLOGY, 2019, 36 (02) : 265 - 267
  • [6] Botulinum toxin type A for the treatment of nummular headache: Four case studies
    Mathew, Ninan T.
    Kailasam, Jayasree
    Meadors, Lori
    [J]. HEADACHE, 2008, 48 (03): : 442 - 447
  • [7] Substance P as an immunomodulatory neuropeptide in a mouse model for autoimmune hair loss (Alopecia Areata)
    Siebenhaar, Frank
    Sharov, Andrey A.
    Peters, Eva M. J.
    Sharova, Tatyana Y.
    Syska, Wolfgang
    Mardaryev, Andrei N.
    Freyschmidt-Paul, Pia
    Sundberg, John P.
    Maurer, Marcus
    Botchkarev, Vladimir A.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 (06) : 1489 - 1497
  • [8] Simakou T, 2018, ALOPECIA AREATA MULT
  • [9] WANG F, 1992, J BIOL CHEM, V267, P21052
  • [10] Nummular Headache
    Wilhour, Danielle
    Ceriani, Claire E. J.
    Nahas, Stephanie J.
    [J]. CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2019, 19 (06)